Cargando…
Quantitative proteomic analysis of cerebrospinal fluid from patients with diffuse large B-cell lymphoma with central nervous system involvement: A novel approach to diagnosis
The outcome of patients with diffuse large B-cell lymphoma (DLBCL) with central nervous system (CNS) recurrence is poor. However, there is currently no consensus regarding diagnostic techniques. The aim of the present study was to investigate the cerebrospinal fluid (CSF) protein profile of DLBCL an...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610216/ https://www.ncbi.nlm.nih.gov/pubmed/31338193 http://dx.doi.org/10.3892/br.2019.1222 |
_version_ | 1783432462817296384 |
---|---|
author | Liu, Xiaobei Mo, Fei Zeng, Hao Zhu, Sha Ma, Xuelei |
author_facet | Liu, Xiaobei Mo, Fei Zeng, Hao Zhu, Sha Ma, Xuelei |
author_sort | Liu, Xiaobei |
collection | PubMed |
description | The outcome of patients with diffuse large B-cell lymphoma (DLBCL) with central nervous system (CNS) recurrence is poor. However, there is currently no consensus regarding diagnostic techniques. The aim of the present study was to investigate the cerebrospinal fluid (CSF) protein profile of DLBCL and identify a potential novel method for the early diagnosis of patients with DLBCL at high risk for subsequent CNS involvement. The CSF proteomic profiling of patients with DLBCL and a control group were compared using label-free liquid chromatography-tandem mass spectrometry. Gene Ontology and pathway analyses were conducted using the Database for Annotation, Visualization and Integrated Discovery. The protein interactions were analyzed using the Search Tool for the Retrieval of Interacting Genes/Proteins database. In the present study, a total of 53 differentially expressed proteins with >1 log(2) fold change (false discovery rate <0.01, P<0.05) were identified and quantified. These proteins appeared to be involved in platelet degranulation, innate immune response and cell adhesion. Two hub gene network modules were obtained by protein-protein interaction network analysis. Of these proteins, secreted protein acidic and rich in cysteine (SPARC) and proenkephalin (PENK) were significantly decreased in the CSF of patients with DLBCL, which appeared to be correlated with CNS involvement. The findings of the present study indicate that decreased expression levels of SPARC and PENK in the CSF may serve as early-phase biomarkers to evaluate the risk of CNS involvement in patients with DLBCL, enabling clinicians to offer prophylactic therapy at the time of diagnosis. |
format | Online Article Text |
id | pubmed-6610216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-66102162019-07-23 Quantitative proteomic analysis of cerebrospinal fluid from patients with diffuse large B-cell lymphoma with central nervous system involvement: A novel approach to diagnosis Liu, Xiaobei Mo, Fei Zeng, Hao Zhu, Sha Ma, Xuelei Biomed Rep Articles The outcome of patients with diffuse large B-cell lymphoma (DLBCL) with central nervous system (CNS) recurrence is poor. However, there is currently no consensus regarding diagnostic techniques. The aim of the present study was to investigate the cerebrospinal fluid (CSF) protein profile of DLBCL and identify a potential novel method for the early diagnosis of patients with DLBCL at high risk for subsequent CNS involvement. The CSF proteomic profiling of patients with DLBCL and a control group were compared using label-free liquid chromatography-tandem mass spectrometry. Gene Ontology and pathway analyses were conducted using the Database for Annotation, Visualization and Integrated Discovery. The protein interactions were analyzed using the Search Tool for the Retrieval of Interacting Genes/Proteins database. In the present study, a total of 53 differentially expressed proteins with >1 log(2) fold change (false discovery rate <0.01, P<0.05) were identified and quantified. These proteins appeared to be involved in platelet degranulation, innate immune response and cell adhesion. Two hub gene network modules were obtained by protein-protein interaction network analysis. Of these proteins, secreted protein acidic and rich in cysteine (SPARC) and proenkephalin (PENK) were significantly decreased in the CSF of patients with DLBCL, which appeared to be correlated with CNS involvement. The findings of the present study indicate that decreased expression levels of SPARC and PENK in the CSF may serve as early-phase biomarkers to evaluate the risk of CNS involvement in patients with DLBCL, enabling clinicians to offer prophylactic therapy at the time of diagnosis. D.A. Spandidos 2019-08 2019-06-13 /pmc/articles/PMC6610216/ /pubmed/31338193 http://dx.doi.org/10.3892/br.2019.1222 Text en Copyright: © Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Liu, Xiaobei Mo, Fei Zeng, Hao Zhu, Sha Ma, Xuelei Quantitative proteomic analysis of cerebrospinal fluid from patients with diffuse large B-cell lymphoma with central nervous system involvement: A novel approach to diagnosis |
title | Quantitative proteomic analysis of cerebrospinal fluid from patients with diffuse large B-cell lymphoma with central nervous system involvement: A novel approach to diagnosis |
title_full | Quantitative proteomic analysis of cerebrospinal fluid from patients with diffuse large B-cell lymphoma with central nervous system involvement: A novel approach to diagnosis |
title_fullStr | Quantitative proteomic analysis of cerebrospinal fluid from patients with diffuse large B-cell lymphoma with central nervous system involvement: A novel approach to diagnosis |
title_full_unstemmed | Quantitative proteomic analysis of cerebrospinal fluid from patients with diffuse large B-cell lymphoma with central nervous system involvement: A novel approach to diagnosis |
title_short | Quantitative proteomic analysis of cerebrospinal fluid from patients with diffuse large B-cell lymphoma with central nervous system involvement: A novel approach to diagnosis |
title_sort | quantitative proteomic analysis of cerebrospinal fluid from patients with diffuse large b-cell lymphoma with central nervous system involvement: a novel approach to diagnosis |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610216/ https://www.ncbi.nlm.nih.gov/pubmed/31338193 http://dx.doi.org/10.3892/br.2019.1222 |
work_keys_str_mv | AT liuxiaobei quantitativeproteomicanalysisofcerebrospinalfluidfrompatientswithdiffuselargebcelllymphomawithcentralnervoussysteminvolvementanovelapproachtodiagnosis AT mofei quantitativeproteomicanalysisofcerebrospinalfluidfrompatientswithdiffuselargebcelllymphomawithcentralnervoussysteminvolvementanovelapproachtodiagnosis AT zenghao quantitativeproteomicanalysisofcerebrospinalfluidfrompatientswithdiffuselargebcelllymphomawithcentralnervoussysteminvolvementanovelapproachtodiagnosis AT zhusha quantitativeproteomicanalysisofcerebrospinalfluidfrompatientswithdiffuselargebcelllymphomawithcentralnervoussysteminvolvementanovelapproachtodiagnosis AT maxuelei quantitativeproteomicanalysisofcerebrospinalfluidfrompatientswithdiffuselargebcelllymphomawithcentralnervoussysteminvolvementanovelapproachtodiagnosis |